DAA2326 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
146.8% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2137 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB1 |
83.0% Increase Gene Expression Level |
|
DAA2370 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB1 |
84.8% Increase Gene Expression Level |
|
DAA2371 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB4 |
88.5% Increase Gene Expression Level |
|
DAA2372 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB5 |
64.1% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2348 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
37.9% Increase Gene Expression Level |
|
DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|
DAA1102 |
Myogenic Differentiation 1 |
Molecular |
frontal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA2249 |
NLR family, pyrin domain containing 1 decreases with age |
Molecular |
frontal lobe |
Human |
NLRP1 |
29.4% Decrease Gene Expression Level |
|
DAA2247 |
pannexin 1 decreases with age |
Molecular |
frontal lobe |
Human |
PANX1 |
59.9% Decrease Gene Expression Level |
|
DAA2351 |
Pannexin 2 decreases with age |
Molecular |
frontal lobe |
Human |
PANX2 |
8.1% Decrease Gene Expression Level |
|
DAA1078 |
Pipecolic Acid Oxidase |
Molecular |
frontal lobe |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA1094 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
frontal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1086 |
Rhomboid Domain Containing 1 |
Molecular |
frontal lobe |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA2243 |
S100 calcium binding protein A8 increases with age |
Molecular |
frontal lobe |
Human |
S100A8 |
921.4% Increase Gene Expression Level |
|
DAA2244 |
S100 calcium binding protein A9 increases with age |
Molecular |
frontal lobe |
Human |
S100A9 |
92.8% Increase Gene Expression Level |
|
DAA1098 |
Schlafen Family Member 11 |
Molecular |
frontal lobe |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA718 |
Synaptic density slightly decreases at advanced ages |
Physiological |
frontal lobe |
Human |
— |
— |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
250.2% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|